appears in the following:
Tornado damage to Pfizer factory highlights vulnerabilities of drug supply
Thursday, July 27, 2023
A tornado that ripped through a Pfizer plant in Rocky Mount, N.C., raised worries about shortages of medicines used in hospitals. The drugs include commonly used painkillers and anesthetics.
Here are the drugs that could be in short supply after a tornado hit a Pfizer factory
Wednesday, July 26, 2023
A tornado that tore through a Pfizer factory in North Carolina could exacerbate drug shortages. Records obtained by NPR show the plant made dozens of products, including painkillers and anesthetics.
Blockbuster drug Humira finally faces lower-cost rivals
Thursday, July 20, 2023
After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.
Copycat drugs could end Humira's reign as the prominent arthritis treatment
Wednesday, July 19, 2023
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign.
Copycat drugs could end Humira's reign as the prominent arthritis treatment
Tuesday, July 18, 2023
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now some copycats could end Humira's reign.
Russia halts participation in the Black Sea Grain Initiative
Monday, July 17, 2023
Russia announced it is suspending participation in the Black Sea Grain Initiative, as a key bridge linking annexed Crimea to the Russian mainland was attacked again.
FDA approves the first over-the-counter birth control pill, Opill
Thursday, July 13, 2023
The Food and Drug Administration has approved the first over-the-counter birth control pill. The daily oral contraceptive, called Opill, will be available without a prescription.
Families scramble to find growth hormone drug as shortage drags on
Monday, May 15, 2023
Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year.
Here's what really happened during the abortion drug's approval 23 years ago
Friday, April 14, 2023
A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here's what really went down.
Strep is bad right now — and an antibiotic shortage is making it worse
Monday, April 10, 2023
Strep throat is more prevalent this year, and amoxicillin manufacturers didn't make enough of the antibiotic to go around.
A drug shortage is making it harder for doctors to treat strep throat
Sunday, April 09, 2023
There's a nationwide shortage of the antibiotic amoxicillin. It is making it harder for doctors to treat strep throat.
Dueling rulings lead to confusion over abortion drug access
Saturday, April 08, 2023
Future access to the abortion drug mifepristone is called into question following competing rulings from federal judges in Texas and Washington State.
FDA pulls the only approved drug for preventing premature birth off the market
Thursday, April 06, 2023
The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.
The opioid overdose reversal drug Narcan has been approved for sale over the counter
Wednesday, March 29, 2023
The FDA approved Narcan for sale without a prescription. The opioid overdose reversal drug would be available at pharmacies and convenience stores nationally, increasing access as opioid deaths climb.
Senators grilled Moderna's CEO about spiking the price of its COVID-19 vaccine
Wednesday, March 22, 2023
Moderna is quadrupling the price of its COVID-19 vaccine when the U.S. government is no longer the exclusive buyer. Senators grilled the company's CEO on the hike and access for the uninsured.
Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured
Wednesday, March 08, 2023
Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.
FDA has new leverage over companies looking for a quicker drug approval
Friday, March 03, 2023
The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.
Moderna announced a free COVID vaccine program. But will that be accessible enough?
Thursday, March 02, 2023
Moderna said people without insurance will be able to get its COVID vaccine at no cost after the U.S. government bows out. But patients will have to use the company's cumbersome assistance program.
Eli Lilly cuts some older insulin prices and caps out-of-pocket costs
Wednesday, March 01, 2023
An insulin maker is cutting its prices. Eli Lilly, one of the three makers of insulin products in the United States, is also making other moves toward affordability for people with diabetes.
The FDA recently gained more leverage over pharmaceutical companies. Will it use it?
Saturday, February 25, 2023
The U.S. Food and Drug Administration late last year got more leverage over pharmaceutical companies that received accelerated approvals for their drugs. How will the agency use its new powers?